For example, although hypermethylation of SOCS2 CpG islands was detected in 14% of ovarian cancer patients (Sutherland et al., 2004), our studies here revealed that oncogenic N-Ras has minimal impact on DNA methylation of the Socs2 promoter. Here, NRAS is linked to ovarian cancer.